| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.02 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.077 | 0.02 |